Explorium customers: we match your credits, up to 3x on top-ups. Ends Dec 2Claim your creditsArrow
ADARx Pharmaceuticals Inc. logo

ADARx Pharmaceuticals Inc.

Our vision is to provide effective and safe RNA therapeutics to patients who suffer from intractable diseases.

Last updated: . For recent data, use our API.

Overview

ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases. ADARx Pharmaceuticals is well-financed by a syndicate of renowned VC firms. Founded in 2019, ADARx has about 71 employees. The company is publicly traded under the stock symbol ADRX.

ADARx currently has multiple active programs in development. Its lead candidate is at the clinical stage. Its pipeline consists of siRNA therapeutic candidates designed to deliver deep and durable reduction of target proteins with infrequent dosing.

Funding rounds

Disclosed funding: $413.5M across 7 rounds. Latest: Venture Round, 1 Feb 2025.

DateTypeAmount
1 Feb 2025Venture Round$50M
More funding rounds via API
Get company data via API

Get company records through the Enrich Layer API. These pages show previews only.

Office locations

Similar companies

ADARx Pharmaceuticals Inc. FAQ

As of 2026-10-29, ADARx Pharmaceuticals Inc. has 71 employees, based on the Enrich Layer count of person profiles that list ADARx Pharmaceuticals Inc. as their current employer. Its listed company size band is 51 to 200.
As of 2026-10-29, ADARx Pharmaceuticals Inc. is headquartered in San Diego, CA, US.
ADARx Pharmaceuticals Inc. was founded in 2019.
As of 2026-10-29, ADARx Pharmaceuticals Inc. is classified in the Biotechnology Research industry.
ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases. ADARx Pharmaceuticals is well-financed by a syndicate of renowned VC firms.
As of 2026-10-29, ADARx Pharmaceuticals Inc.'s official website is http://adarx.com/.
As of 2026-10-29, ADARx Pharmaceuticals Inc. is a privately held company.